The class of BTF3 Activators is a conceptual category encompassing various chemical compounds that indirectly influence the activity of BTF3, a fundamental component of the transcription machinery. These compounds primarily include inhibitors of DNA methyltransferases and histone deacetylases (HDACs), which play a pivotal role in modulating the chromatin landscape and, consequently, the transcriptional activity.
These chemical activators, through their distinct but converging mechanisms of action, bring about alterations in the epigenetic status of chromatin, thus influencing the transcriptional activities where BTF3 is a key player. For instance, DNA methyltransferase inhibitors like 5-Azacytidine and RG108 reduce DNA methylation levels, leading to a more open chromatin state. This change in the chromatin structure can potentially facilitate the transcriptional functions of BTF3 by making gene promoters more accessible to the transcription machinery. Similarly, HDAC inhibitors, including but not limited to Trichostatin A, Vorinostat, and Valproic Acid, increase histone acetylation levels. This increase in acetylation typically correlates with an active chromatin state, conducive to transcription. By altering the histone acetylation landscape, these inhibitors can indirectly modulate the transcriptional environment in which BTF3 operates.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor. By inhibiting DNA methylation, it can lead to changes in chromatin structure, potentially affecting BTF3's role in transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor. It alters acetylation patterns on histones, which could indirectly influence BTF3's transcriptional activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, similar in function to Trichostatin A, potentially affecting BTF3 activity by altering histone acetylation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A short-chain fatty acid and a histone deacetylase inhibitor. It can influence chromatin remodeling, potentially affecting BTF3's activity. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
An inhibitor of G9a and GLP histone lysine methyltransferases. By altering methylation patterns, it may indirectly influence BTF3 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor. It can change DNA methylation patterns, potentially influencing BTF3's transcriptional function. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor. By altering histone acetylation, it may indirectly affect BTF3 activity. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A histone deacetylase inhibitor. It can modify chromatin structure and potentially influence BTF3 activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent histone deacetylase inhibitor. Its action on histone acetylation could indirectly affect BTF3. | ||||||
PI3K/HDAC Inhibitor | 1339928-25-4 | sc-364584 sc-364584A | 5 mg 10 mg | $347.00 $471.00 | ||
A dual PI3K and histone deacetylase inhibitor. It could indirectly influence BTF3 by altering multiple pathways involved in chromatin remodeling. | ||||||